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Abstract
Background: Osteoarthritis (OA) is a debilitating, progressive joint disease.
Methods: Similar to the disease progression in humans, sequential events of early cartilage degradation,
subchondral osteopenia followed by sclerosis, and late osteophyte formation were demonstrated in the anterior
cruciate ligament transection (ACLT) or ACLT with partial medial meniscectomy (ACLT + MMx) rat OA models. We
describe a reliable and consistent method to examine the time dependent changes in the gene expression profiles
in articular cartilage and subchondral bone.
Results: Local regulation of matrix degradation markers was demonstrated by a significant increase in mRNA levels
of aggrecanase-1 and MMP-13 as early as the first week post-surgery, and expression remained elevated
throughout the 10 week study. Immunohistochemistry confirmed MMP-13 expression in differentiated
chondrocytes and synovial fibroblasts at week-2 and cells within osteophytes at week-10 in the surgically-modified-
joints. Concomitant increases in chondrocyte differentiation markers, Col IIA and Sox 9, and vascular invasion
markers, VEGF and CD31, peaked around week-2 to -4, and returned to Sham levels at later time points in both
models. Indeed, VEGF-positive cells were found in the deep articular chondrocytes adjacent to subchondral bone.
Osteoclastic bone resorption markers, cathepsin K and TRAP, were also elevated at week-2. Confirming bone
resorption is an early local event in OA progression, cathepsin K positive osteoclasts were found invading the
articular cartilage from the subchondral region at week 2. This was followed by late disease events, including
subchondral sclerosis and osteophyte formation, as demonstrated by the upregulation of the osteoanabolic
markers runx2 and osterix, toward week-4 to 6 post-surgery.
Conclusions: In summary, this study demonstrated the temporal and cohesive gene expression changes in
articular cartilage and subchondral bone using known markers of OA progression. The findings here support
genome-wide profiling efforts to elucidate the sequential and complex regulation of the disease.
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Background
Osteoarthritis (OA) is a joint disease that involves
degeneration of cartilage, limited synovitis, subchondral
bone changes, and osteophyte formation [1]. Mechanical
stress associated with joint instability is thought to
induce changes in biochemical factors within affected
joints leading to focal articular cartilage degradation [2].
However, recent evidence indicates that it is also neces-
sary to consider the contributions of synovial inflamma-
tion and subchondral bone changes [3]. The integrity of
the articular cartilage has been proposed to depend on
the biomechanical properties of the underlying bone [4].
Subchondral bone changes detected by 99mTc scintigra-
phy appeared to precede radiographic signs of structural
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have documented acceleration of subchondral bone
turnover accompanied by specific architectural changes
in the subchondral trabecular bone of the OA joints
[6-9]. Furthermore, epidemiologic studies have corre-
lated both the increases in bone mineral density and in
the rate of bone turnover, as determined by biochemical
markers, with increases in the incidence and severity of
osteoarthritis [10-12]. Because the subchondral bone is
critically important in containing the mechanical
abnormalities that damage the cartilage, emphasis on a
panel of biomarkers of bone remodeling resulting from
the abnormal stresses on the joint has been proposed as
diagnostic tools used to monitor treatment responses to
potential structure-modifying drugs [13,14]. The
mechanical and biochemical properties of the subchon-
dral bone are therefore of particular interest in any
attempt to determine the molecular mechanisms
responsible for initiating osteoarthritis.
Currently, no OA animal models fully mimic the
pathogenesis of the human disease and the surgical mod-
els of mechanical instability appear to represent chronic,
traumatic OA. Among these models, the anterior cruciate
ligament transection model in dogs and the partial
menisci resection model in rabbits have been widely used
to study the histological and biochemical changes occur-
ring during OA progression [15]. As the metabolism of
articular cartilage and particularly of the subchondral
bone in these species is not completely understood,
further analysis of molecular changes in the joints of
these species during disease progression is warranted.
We have previously reported the characterization of the
morphological and histological changes in cartilage and
subchondral bone in two different models of surgically-
induced OA in the rat, the anterior cruciate ligament
transection (ACLT) model or the ACLT in combination
with partial medial meniscectomy (ACLT+MMx) [16]. In
both models, OA-related pathogenic changes occurred in
a time dependent manner with milder and slower disease
progression in ACLT, as compared with ACLT+MMx.
Surface cartilage damage and accelerated subchondral
bone resorption were observed within 2-weeks post-sur-
gery. Significant cartilage thinning, subchondral sclerosis
and osteophyte formation were demonstrated as late
stage disease events. Here, we focus on evaluating mole-
cular changes of OA progression in these two surgically-
induced models of joint instability in rats in order to
further our understanding of the relationship between
subchondral bone changes and cartilage degradation.
Methods
Osteoarthritis model and treatment
All procedures were carried out in accordance with the
Institutional Animal Care and Use Committee in Merck
Research Labs. A total of 144 intact male Sprague-Daw-
ley rats (Taconic, NY) were used in three time course
studies.
Detailed development and characterization of the
osteoarthritis (OA) models were previously reported
[16]. In brief, the two OA models were surgically
induced in 10 week-old male rat right knee joints with
some modifications. Rats were anesthetized with isoflur-
ane. After shaving the right knee joint, the skin was dis-
infected with iodine. The knee joint was exposed though
the medial parapatellar approach. The patella was dislo-
cated laterally and the knee placed in full flexion. The
anterior cruciate ligament (ACL) was then transected
with micro-scissors; complete transection was confirmed
with the anterior drawer test. In the more severe model
of OA, anterior cruciate ligament transection (ACLT)
with partial medial meniscectomy (ACLT+MMx), the
medial collateral ligament was additionally transected
with resection of medial meniscus. Following surgery,
the joint surface was washed with sterile saline solution,
and both capsule and skin were sutured using Vicryl 4-0
(Ethicon, Edinburgh, UK), absorbable suture and mono-
filament 4-0 Nylon threads (Ethicon, Edinburgh, UK).
In the sham operation, after subluxation of patella
with the same procedure as OA model, the wound was
closed by layers. All operation procedures were per-
formed using a surgical loupe. Buprenorphine hydro-
chloride (0.1 mg/kg) (Reckitt & Colman Products Ltd.,
Hull, England) was given as a post-operative analgesic.
Rats were allowed to move freely in the soft bedding in
plastic cages.
The initial time-course study followed the animals for
1-, 2-, 4-, 6-, and 10-wk post-surgery. Two repeat time-
course studies were performed for 2-, 4-, and 10-wk and
1-, 2-, and 10-wk post-surgery, respectively. Each of the
study groups had six animals for each time point.
RNA collection
The surgical (right) and contra-lateral (left) tibiae from
each group (Sham, ACLT, ACLT+MMx) were rapidly
dissected from animals at 1, 2, 4, 6, and 10-wk post-sur-
gery. Tibiae were thoroughly cleaned to remove muscle
and ligament as well as joint capsule, without causing
undue damage to the tibia plateau. Each tibia was then
mounted in a precision bone saw such that the medial
side of the bone was oriented parallel to the holding
clamp, while the head of the bone was oriented perpen-
dicular to the clamp. Using an Isomet low speed bone
saw (Beuhler, Lake Bluff, IL) three cuts were made from
the end of each tibia. Slice #1: was approximately 960
μm from the tibial plateau and contained articular carti-
lage (~200 μm) and subchondral bone (~760 μm). Slice
#2: was approximately 1440 μm and contained epiphy-
seal bone (~1060 μm) and growth plate (~280 μm).
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metaphyseal bone. Each bone slice was placed in saline
and flushed with a 23 gauge needle to remove bone
marrow. They were quickly frozen in liquid nitrogen
and stored at -135°C until processing. The whole pro-
cess of tissue collection normally took less than 10 min-
utes from necropsy to freezing of the cartilage and bone
slices. Bone slices were pooled for each cut within a
group.
RNA isolation from Bone and Cartilage
Frozen bone slices were immersed in liquid nitrogen
and then crushed prior to addition to Trizol reagent
(Invitrogen, CA). Samples were homogenized using a
Polytron (Brinkman Instruments). Total RNA was iso-
lated according to manufacturer’s directions with minor
modifications. Following the chloroform extraction step,
RNA was re-extracted with acidic phenol:chloroform to
remove proteoglycans. RNA was precipitated with iso-
propanol and washed with 75% ethanol. After pellet was
air-dried, RNA was resuspended in molecular biology
grade water and concentration of each sample was
determined by measuring the absorbance at 260 nm.
Agarose gel electrophoresis was used to confirm RNA
integrity.
TaqMan probes and primers
Primers and fluorogenic probes were designed using Pri-
mer Express v. 1.0 (Applied Biosystems, CA) and are
listed in Table 1. All probes were synthesized by
Applied Biosystems with the fluorescent reporter dye
FAM (6-carboxy-fluorescein) attached to the 5’-end and
the quencher dye TAMRA (6-carboxy-tetramethyl-rho-
damine) attached to the 3’-end. When genomic
sequence was available, primers and probes were
designed to span intron-exon boundaries. Amplified
products were designed to be between 70-110 bp.
All primer/probe pairs were checked for efficiency of
amplification using reverse transcribed rat bone total
RNA. Standard curves were generated using serial dilu-
tions of known quantities of total RNA in duplicate.
Reverse transcription and TaqMan real-time quantitative
PCR
Reverse transcription (RT) reactions were carried out for
each RNA sample in MicroAmp reaction tubes using
TaqMan reverse transcription reagents. Each reaction
tube contained 250 ng of total RNA in a volume of 50
μL containing 1× TaqMan RT buffer, 5.5 mM MgCl2,
500 μM of each dNTP, 2.5 μM of oligo-d(T)16 primers,
2.5 μM of random hexamers, 0.4 U/μLR N a s ei n h i b i t o r
and 1.25 U/μL MultiScribe Reverse Transcriptase. RT
reaction was carried out at 25°C for 10 min, 48°C for 30
min and 95°C for 5 min. The RT reaction mixture was
then placed at 4°C for immediate use in PCR amplifica-
tion or stored at -20°C.
Real-time PCR was performed in a MicroAmp Optical
96-well reaction plate. For each 50 μL reaction, 10 μLo f
RT product (50 ng total RNA), 100 nM forward primer,
100 nM reverse primer, 200 nM probe and 1× Universal
Master Mix (Applied Biosystems) were combined.
Amplification conditions were 2 min at 50°C, 10 min at
95°C followed by 40 cycles at 95°C for 15 sec, 60°C for
1 min. All reactions were performed in ABI Prism 7700
Sequence Detection System in duplicate. Data collected
represents an average from replicate studies for week 1,
2, 4, and 10 and one study for week 6. Expression levels
of mRNA were corrected for expression relative to the
housekeeping gene, Cyclophilin A, and were expressed
as fold change relative to sham levels.
Immunohistochemistry
Resected knee joints were fixed with 4% paraformalde-
hyde (Merck, Darmstadt, Germany) in 0.1 M phosphate
buffer solution (pH 7.5) for 24 hours at 4°C. After the
fixation, the tissues were rinsed with PBS. Tissues were
decalcified in 0.5 M ethylene diamine tetra acetate
(EDTA) solution (pH 7.6) with stirring in 4°C, then
dehydrated in a graded ethanol series and defatted in
chloroform to embed into the paraffin wax (Fisher
Scientific, NJ, USA). Normal and OA cartilage speci-
mens were examined by histological analysis and
immunohistochemistry.
All tissues from the first time course study were pro-
cessed for tissue sections and randomly selected from
each group (N = 6) for immunohistochemical evalua-
tions. Tissue sections were deparaffinized in xylene,
hydrated in graded ethanol, then treated with 500 U/ml
testicular hyaluronidase (Sigma, MO) at 37°C for 20
min. Tissue sections were incubated with anti-MMP-13
Ab, a cocktail of anti-MMP-9 polyclonal (Cell Sciences,
MA) and anti-cathepsin K (CatK) mAb (Oncogene, CA)
or a cocktail of anti-VEGF polyclonal (Neomarkers, CA)
and anti-KDR mAb (Accurate chemical & scientific Co.,
NY). All were incubated overnight at 4°C, as described
previously [17]. For MMP-13 immunostaining, after rin-
sing in PBS with 0.3% Tween 20, sections were incu-
bated with biotin-conjugated anti-rabbit Ab (Vector
Laboratories, CA) for 30 min, followed by alkaline phos-
phatase-conjugated streptavidin for 30 min (Vector
Laboratories, CA). These sections were rinsed with PBS,
and developed using the fast red substrate system
(Dako, CA) for 5 min, counterstained with hematoxylin.
Double-labeled immunohistochemical staining for cathe-
psin K/MMP-9 and VEGF/KDR was performed simulta-
neously. Briefly, tissue sections were incubated with a
cocktail of mouse monoclonal and rabbit polyclonal
antibodies, followed by incubation with a cocktail of
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anti mouse antibody (DAKO, CA) for 1 hr, and incu-
bated with alkaline phosphatase-conjugated streptavidin
for 30 min (Vector Laboratories, CA). Alkaline phospha-
tase was colored either blue (VEGF) or red (MMP-9)
color with AP blue (Vector Laboratories, CA) or fast red
(DAKO, CA) respectively. They were washed twice with
PBS for 1 hr, followed by development to brown color
using 0.5 mg/ml 3, 3’-diaminobenzidine tetrahydrochlor-
ide. For controls, the same procedures were carried out
either without primary Ab or with mouse mAb IgG
instead of primary antibody.
Table 1 Oligonucleotides and TaqMan fluorogenic probes
Gene Genebank Primer Sequence 5’-3’ Amplicon
Aggrecanase-1 NM_023959 Forward CTGCATCTGCCAGTGACTTTTC 74
Reverse TCAGGACCAAAGGTCAGTTGG
Probe TGGCAAGGACTATGATGCTGACCGC
Bone Sialoprotein NM_012587 Forward GTTGGAGTTAGCTGCGCTCC 90
Reverse TCCTCTTCCTCGTCGCTTTCCTTCATT
Probe AAGGCTGGAGATGCAGAGGGCAAGG
Cathepsin K NM_031560 Forward GCCATGAATCACCTGGGAGA 76
Reverse GCGAAGGTGGCACTCTGAGT
Probe TGACCAGCGAAGAAGTGGTTCAGAAGATGA
Cbfa-1/Runx2 AF325502 Forward TGCTTCATTCGCCTCACAA 71
Reverse CTTGCTGTCCTCCTGGAGAAA
Probe AACCACAGAACCACAAGTGCGGTGC
CD31 NM_031591 Forward TCAACAGAGCCAGCATTGTGA 70
Reverse CACGGAGCAAGAAAGACTCTGA
Probe CAGTCTCCGAAGCGGCCCTCTAACA
Collagen Type IIA NM_031163 Forward TCTGCAGAATGGGCAGAGGTATA 103
Reverse GATAATGTCATCGCAGAGGACATTC
Probe AAGCCCTCATCTTGCCGCATCTGTG
Cyclophilin A NM_017101 Forward CAAATGCTGGACCAAACACAA 70
Reverse GCCATCCAGCCACTCAGTCT
Probe TGGTTCCCAGTTTTTTATCTGCACTGCC
KDR NM_013062 Forward ACGTTTGAGAACCTCACGTGG 84
Reverse CTTGCAAACTGGTGTGAGTGATTC
Probe AGCTTGGCTCACAGGCAACATCGG
MMP-13 NM_133530 Forward AGTCCTTTTGGCCAGAACTTCC 76
Reverse AAGATGAACATGAGGTCTCGGG
Probe CCATGTGGATGCTGCATACGAGCATC
Osterix NM_181374 Forward TGACTGCCTGCCTAGTGTCTACA 94
Reverse ACCTGGTGAGATGCCTGCA
Probe ATGTCCCATCCCTACGGCTCCTGGTA
Osteopontin NM_012881 Forward TCTGATGAACAGTATCCCGATGC 84
Reverse GACCTTGATAGCCTCATCGGAC
Probe AGGACCTCACCTCCCGCATGAAGAG
Sox-9 AB073720 Forward CGCAGGAAGCTGGCAGAC 76
Reverse GTCTCCAGAGCTTGCCCAGA
Probe CCGCATCTGCACAACGCGGA
TRAP NM_019144 Forward AATTGCCTACTCCAAGATCTCCAA 74
Reverse GCGGAACTTTGAAACGCAAA
Probe CGCTGGAACTTCCCCAGCCCTTATTA
VEGF NM_031836 Forward AGCCCATGAAGTGGTGAAGTTC 71
Reverse CCACCAGGGTCTCAATTGGA
Probe TGGACGTCTACCAGCGCAGCTATTGC
Exon/intron boundaries are indicated with underlined bases. Exon/intron boundaries for Cathepsin K, TRAP, MMP-9, and
VEGF are assumed by comparison to mouse sequence.
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Collection of articular cartilage and subchondral bone
from the surgically induced joint instability models in the
rats
In this study, we initially focused on developing a reli-
able method for serially collecting the articular cartilage
and subchondral bone, the epiphyseal and metaphyseal
bone slices from the tibeal plateaux of surgically modi-
fied (right) and contra-lateral sham-operated (left) joints
for RNA processing. A previous study evaluated time-
dependent macroscopic changes in the surgical joint of
both OA models in comparison to Sham; detectable
changes in the articular cartilage surface at 6 weeks was
noted for both ACLT and ACLT + MMx models [17].
To gauge the depth of discrete tissue layers, toluidine
blue sections of tibiae from age-matched animals were
examined. The resulting measurements were used to
calibrate the precision bone saw used for tissue collec-
tion for RNA processing. As shown in Figure 1, slice 1
contains the articular cartilage and the proximal sub-
chondral bone layer, collected from the first 960 μm
measured from the tibial surface; slice 2 contains mostly
the epiphyseal bone and growth plate, spanned the next
1440 μm; and slice 3 contains the metaphyseal bone,
collected from the adjacent 1440 μm.
From a study with aged matched rats subjected to
either sham-operated, or to anterior cruciate ligament
transection (ACLT) alone or transection of both ACL
and medial collateral ligament and partial resection of
medial meniscus (ACLT+MMx), total RNA extracted
from the three tissue slices was found to have high qual-
ity and relatively consistent amounts between the col-
lected individual joints. To minimize animal variability,
six slices per group were combined for each time point.
Total RNA isolated from the first slices containing both
articular cartilage and subchondral bone was evaluated
by real time PCR using known gene markers for carti-
lage and bone catabolism and anabolism (Table 2). It
should be noted that the real time PCR data represented
the averaged values from three independent time-course
experiments.
In articular cartilage and subchondral bone slices
(slice#1), there were time-dependent and marked
changes in the expression profiles of known cartilage
degeneration genes in response to either ACLT or
ACLT+MMx surgically induced joint instability, as com-
pared to those in the contra-lateral left joints and
Sham-operated joints (Figure 2A). However, there were
only subtle differences in the profiles of these cartilage
and bone makers in the epiphyseal (slice#2) and meta-
physeal (slice#3) slices in the ACLT or ACLT+MMx
joints as compared to the contra-lateral joints (Figure
2 Ba n dd a t an o ts h o w n ) .T h e r e f o r e ,i nt h i ss t u d y ,w e
focused further analyses in slice 1 to study regulation of
key markers (Table 2) for cartilage matrix degradation
(aggrecanase-1, metalloproteinase-13 (MMP-13)), chon-
drocyte differentiation (collagen IIA and Sox 9), angio-
genesis (VEGF, CD31, KDR), bone resorption (cathepsin
K and tartrate resistant acid phosphatase (TRAP)) and
bone formation (runx2, osterix, bone sialoprotein and
osteopontin).
Early regulation of markers for matrix degradation in the
articular cartilage and subchondral bone in the rat
models of joint instability-induced osteoarthritis
The gene expression patterns during disease progression
in the ACLT and ACLT+MMx models of joint instabil-
ity versus Sham-operated animals were characterized by
mRNA levels using real time PCR and confirmed by
protein levels using immunohistochemical methods.
Early changes evident in OA include surface cartilage
damage and subchondral bone remodeling. As shown in
Figure 2A, aggrecanase-1 and MMP-13, proteolytic
enzymes which degrade the cartilage matrix, were up-
regulated as early as week 1 in both OA models as com-
pared to Sham. Expression levels of aggrecanase-1
aggressively increased 3-4 fold in both ACLT+MMx and
ACLT models, respectively, relative to Sham (Figure 2A-
a; Table 2). The aggrecanase-1 mRNA expression levels
(1) 960 µm
(2) 1440 µm
(3) 1440 µm
(1)  Articular Cartilage + Subchondral Bone
(2)  Epiphyseal Bone + Growth Plate
(3)  Metaphyseal Bone 
Tissue slices:
Figure 1 Schematic representation of tibia sectioning for RNA
collection. Tibiae were serially sectioned using a precision bone
saw to obtain bone slices representing discrete areas. Three
successive bone slices were prepared according to calibration
measurements previously determined from toluidine blue stained
sections of aged-matched rodents. The section of primary interest
was obtained from the initial slice and included the entire articular
cartilage layer and proximal subchondral bone (~760 μm) and
measured a total of 960 μm. Slice 2 was predominantly epiphyseal
bone and growth plate and measured 1440 μm. The third slice
included the adjacent 1440 μm containing metaphyseal bone.
Sections two and three were collected as internal controls.
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to 10-week post-surgery, supporting the relevant role of
this enzyme in cartilage degeneration during the initial
and progressive phases of OA.
The regulation of MMP-13 synthesis was similar, yet
more modest, to that of aggrecanase-1 in ACLT and
ACLT+MMx joints. MMP13 expression levels in the
transected joints were elevated by ~2- fold as early as
week 1, relative to Sham and remained elevated relative
to Sham peaking at 3-5 fold by week 10 (Figure 2A-b;
Table 2). Remarkably, regulation of these two enzyme
markers was specific to the diseased joint as their
respective levels were not different in contra-lateral
intact joints (left), relative to Sham-operated joints (Fig-
ure 2A-c, 2d). Furthermore, there were no changes in
aggrecanase-1 (data not shown) or in MMP-13 mRNA
levels (Figure 2B-a, 2b) detected in deeper epiphyseal
and metaphyseal bone tissue layers (slices 2 & 3) in any
treatment group.
Immunohistochemical staining of the frontal section
of the medial tibeal plateau and growth plate demon-
strated sustained MMP-13 expression as shown in Fig-
ure 2C. In the ACLT + MMx model, protein levels of
MMP-13 were apparent in the differentiated chondro-
cytes and synovial cells of the cartilage surface (Figure
2C-a) at 2 weeks following surgery. There was low, but
detectable MMP-13 protein levels evident in the Sham
articular cartilage, i.e. in a few cells in the deep zone
(Figure 2C-b). At week 10 post-surgery, significant
cartilage thinning and fraying, accompanied with
advancement of subchondral bone and osteophyte for-
mation (Figure 2C-c, arrowheads) were readily detected
as a late stage event of OA progression. Osteochondral
progenitors within the osteophyte region showed high
levels of MMP-13 protein expression (Figure 2C-d with
inset and Figure 2C-e, shown at high magnification of
inset) within proximity to areas of vascular invasion. As
ap o s i t i v ec o n t r o l ,w es t a i n e df o rM M P - 1 3p r o t e i n s
known to be highly expressed in hypertrophic chondro-
cytes in the epiphyseal bone and growth plate (slice 2)
of the ACLT+MMx joints in rats (Figure 2C-f). Similar
to the results obtained from the real time PCR study,
MMP-13 expression levels although expressed in high
abundance, were not regulated in tissue slice 2 in
response to ACLT or ACLT+MMx as compared to
Sham or contra-lateral intact joints (Figure 2B).
Temporal regulation of gene markers for chondrocyte
differentiation in the rat models of osteoarthritis
Evidence has been presented suggesting that phenotypic
alteration in articular chondrocytes is a facet of disease
progression in OA [18]. Chondrocyte differentiation has
been demonstrated to be an early event in disease pro-
gression with increased expression of collagen IIA (Col
IIA), a splice variant normally expressed in chondropro-
genitor cells during embryonic development [19]. Here,
the ACLT model showed a 2-fold increase in Col IIA,
relative to Sham at week 1, peaked at 3-fold through
Table 2 Summary of gene expression patterns regulated in joint-instability induced osteoarthritis progression in rats
(slice#1)
Gene ACLT ACLT+MMx
(Fold increase over Sham in articular cartilage/subchondral bone region)
Week post-surgery 12461 0 12461 0
Matrix Degradation
Aggrecanase I 4.3 2.1 2.5 1.6 2.6 4.2 1.7 2.9 2.3 3.2
MMP13 2.8 1.6 1.9 2.0 4.3 3.7 1.6 2.0 2.2 5.8
Chondrocyte differentiation
Collagen IIA 2.3 2.0 2.8 1.3 1.3 1.8 1.5 2.2 1.4 1.2
Sox 9 2.6 1.8 1.4 1.4 0.8 1.8 1.1 1.4 1.8 1.4
Angiogenesis
VEGF 1.3 2.1 1.6 1.8 1.1 1.7 1.3 1.8 1.3 1.6
CD31 2.1 3.1 1.6 1.8 1.4 2.2 2.0 1.9 1.4 2.3
KDR 1.3 3.2 1.3 1.3 1.1 1.4 2.2 1.3 1.2 1.3
Bone resorption
Cathepsin K 1.5 1.5 1.8 2.7 2.5 1.8 1.9 2.1 2.0 4.1
TRAP
Bone formation
Runx2/cbfa-1 0.7 1.0 1.1 1.8 1.2 0.9 0.9 1.5 1.8 2.0
Osterix 0.7 0.9 1.0 1.7 1.1 1.2 0.9 1.6 1.6 1.6
Bone sialoprotein 1.1 1.4 1.7 1.8 1.6 1.6 1.3 1.5 1.9 2.9
Osteopontin 1.3 1.3 1.9 1.5 1.8 1.7 1.1 1.8 2.4 4.1
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Figure 2 Up-regulation of matrix degradation markers as an early gene regulation event in the surgically-induced models of
osteoarthritis. (A) Up-regulation of matrix degradation markers was seen as early as one week following surgery. (a) Aggrecanase-1
demonstrated early increases of 3-4 fold in ACLT+MMx and ACLT models, respectively. High levels of expression were maintained throughout
the 10 wks of study duration. (b) MMP-13 levels were elevated 2-fold at wk 1 post-surgery. Levels progressively increased by 3 to 5-fold relative
to Sham through wk 10. (c, d) Expression levels of both markers were unaffected in contra-lateral joints over entire time course. (B) No changes
in MMP-13 mRNA expression were observed in deep tissue slice 2 (a) or slice 3 (b). Similar results were observed for aggrecanase-1. All values
are shown as mean ± SD. (C) Frontal section of medial tibial plateau and growth plate were stained with anti-MMP-13 (a, b, d, e, and f) or
toluidine blue-O (c). Articular cartilage, including growth plate, at wk 2 (a and b) and at wk 10 (c, d, e, and f) post-surgery are shown. (a) ACLT
+MMx OA joint highly expressed MMP-13 in differentiated chondrocytes (closed arrowheads) and synovial cells on cartilage surface (arrow). (b)
In sham joint, few cells are MMP-13 positive in deep zone (arrows). (c) Arrows indicate osteophyte formation in periarticular region of the medial
tibial plateau of ACLT-MMx. (d) MMP-13 immunostaining of semi-serial section of (c). (e) Higher magnification of osteophyte region (inset in d)
shows many MMP-13 positive chondrocytes are found in proximity to vascular invasion (open arrowheads). (f) In growth plate, as a positive
control, MMP-13 was intensely stained in hypertrophic chondrocytes. C: articular cartilage. B: bone. V: vascular invasion. GP: growth plate. PS:
primary spongiosa. Bar = 100 μm in (a, b), 500 μm (c, d), 50 μm (e), 200 μm (f).
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Page 7 of 14weeks 2 and 4 and returned to Sham level in week 6 to
10 (Figure 3A; Table 2). Upregulation of Col IIA was
also seen in the ACLT+MMx model, rising steadily to a
m a x i m u mo f2 - f o l da t4 - w e e kp o s t - s u r g e r y ,a n ds u b s e -
quently returned to Sham levels during the later stage of
disease progression (Figure 3A; Table 2). We also inves-
tigated the temporal regulation of Sox 9, a marker for
chondrocyte differentiation. Similar to the Col IIA
expression pattern, Sox 9 expression was upregulated in
ACLT-joints as early as week 1, followed by a progres-
sive return to baseline levels by week 10 (Figure 3B;
Table 2). Although the ACLT+MMx model has been
characterized to have more aggressive disease progres-
sion, the levels of Col IIA and Sox 9 regulation were
lower than those in the ACLT model at weeks 1 and 2
(Figure 3B, Table 2).
Temporal regulation of gene markers for angiogenesis in
the rat models of osteoarthritis
Vascular invasion into calcified cartilage is obligatory in
normal endochondral bone formation and has also been
demonstrated to occur during disease progression in
experimental models of OA. We examined the time-
dependent regulation of typical gene markers for angio-
genesis in tissue slice #1, containing articular cartilage
and subchondral bone. The angiogenesis marker, VEGF,
was up-regulated approximately 2 fold at week 2 and
week 4, in ACLT and ACLT-MM respectively, respond-
ing to joint instability in both surgically-induced models,
(Figure 4A; Table 2). Expression remained elevated rela-
tive to Sham in both models through week 6. As shown
in Table 2, we also examined the regulation profiles of
two other angiogenic markers including CD31 and the
VEGF receptor, KDR. Similar to the regulation pattern
of VEGF, both CD31 and KDR were highly upregulated
at week 2, by ~3-fold in the ACLT joints and by ~2-fold
in the ACLT+MMx joints (Table 2). Expression of these
two vascular markers returned towards Sham levels by
week 10 in the ACLT joints, yet remained slightly ele-
vated above Sham levels up to week 10 post-surgery
(Table 2). in ACLT-MMx joints.
Vascular invasion as an early event in ACLT and
ACLT+MMx joints was further confirmed using immu-
nohistochemistry. From representative thin sections iso-
lated from an ACLT+MMx joint at week 2 post-surgery,
the number of VEGF-positive (blue) hypertrophic chon-
drocyte-like cells significantly increased in the deep
articular cartilage layer, adjacent to subchondral bone
(arrowheads, Figure 4B-a, and inset shown in b). In
proximity to the VEGF-positive chondrocytes, we
detected vascularized structures positive for KDR
(brown) invading the calcified deep cartilage layer
(arrows, Figure 4B-b). In the Sham joint, very few
VEGF-positive stained cells were detected in the deep
zone of articular cartilage (arrow-heads, Figure 4B-c).
However, KDR-positive signals could be readily detected
in vascular endothelial cells in the bone marrow of the
epiphysis, distant from VEGF (arrows, Figure 4B-c).
Progressive increases in gene markers for bone
remodeling in the rat models of osteoarthritis
In addition to cartilage degeneration, subchondral bone
remodeling and osteophytosis are notable events during
the disease progression in both of the surgically-induced
models in rats. We previously documented early invol-
vement of subchondral osteopenia, which was followed
by subchondral sclerosis in response to joint instability
in both ACLT and ACLT+MMx models of OA in rats.
Hence, time dependent regulation of subchondral bone
loss was assessed by two different gene markers specific
for osteoclastic bone resorption, CatK and tartrate
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Figure 3 Temporal regulation of markers of chondrocyte
differentiation in the surgically-induced models of OA. (A)
Collagen IIA was increased by 2-fold in ACLT model at wk 1 relative
to Sham. Expression levels peaked at 3-fold through wk 2 and 4
and returned to Sham levels in wk 6 and 10. (B) Sox 9
demonstrated a similar, those less striking pattern of expression. Sox
9 was upregulated at wk 1 in ACLT and returned to Sham levels in
wk 6 and 10. The fold changes in Col IIA levels were significantly
lower in ACLT+MMx as compared to those in ACLT model. All
values are shown as mean ± SD.
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Page 8 of 14resistant acid phosphatase (TRAP) using real-time PCR
of tissue slice #1. Expression of mRNA levels of CatK
was elevated (1.5 to 2-fold) as early as week 2 post-sur-
gery, then steadily increased to maximal expression (~2
to 4-fold) at week 10 in the ACLT and ACLT+MMx
models, respectively (Figure 5A-a). The pattern of time
dependent regulation of TRAP was similar to that of
CatK (Figure 5A-b), reconfirming these are selective
markers for mature osteoclasts.
The levels of CatK (brown) and MMP-9 (red) were co-
stained using immunohistochemical methods with paraf-
fin embedded sections from typical ACLT+MMx joints
versus Sham joints at week-2 post-surgery (Figure 5B).
At 2 weeks post surgery irregular articular surface was
observed in the OA-joints (arrow, Figure 5B-a). In the
articular cartilage and subchondral regions, CatK expres-
sion was detected in multinucleated osteoclast-like cells
invading into the deep calcified cartilage layer as an early
event in this surgically-induced model (arrowheads, Fig-
ure 5B-a, and inset shown in b). Interestingly, MMP-9-
positive signal (red) was only localized in the extracellular
matrix adjacent to hypertrophic chondrocytes specifically
in proximity to the invading osteoclasts (open arrowhead,
Figure 5B-b). There was no MMP-9 expression detected
in the vicinity of the multinucleated osteoclasts on sub-
chondral bone surfaces (arrowheads, Figure 5B-a). A
similar pattern of MMP-9 expr e s s i o ni nh y p e r t r o p h i c
chondrocytes in proximity to osteoclasts was found at
the border of the growth plate and the mineralized pri-
mary spongiosa (Figure 5B-d). As control, CatK and
MMP-9 were localized to osteoclasts in the subchondral
bone plate of the Sham-joints. No detectable CatK/
MMP-9 positive cells were observed to have invaded the
Sham articular cartilage (data not shown).
Subchondral sclerosis and osteophyte formation occur
late in the disease progression in these experimental
models of OA. Two transcription factors, Runx2/Cbfa1
and osterix, have been shown to play critical roles in
mediating bone anabolism. Runx2 plays the rate-limiting
role in regulating bone formation, and also regulates
osterix during osteoblast differentiation [20]. Neither
runx2 nor osterix increased until the late stages (up to
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Figure 4 Up-regulation of markers of angiogenesis in the surgically-induced models of joint instability. (A) Induction of angiogenesis
gene expression marker, VEGF, was seen at 2-wk post-surgery in both models. Levels of VEGF increased approximately 2 fold at week 2,
maintained expression during wk 4 and 6 and returned to Sham levels by week 10. All values are shown as mean ± SD. (B) Frontal section of
medial tibial plateau and growth plate were stained with anti-VEGF (blue) and anti-KDR (brown). (a) At 2-wk post-surgery, many chondrocytes
differentiated to hypertrophic chondrocytes in ACLT+MMx joint. (b) Higher magnification of inset in (a) showed that hypertrophic chondrocyte-
like cells strongly stained with VEGF (arrowheads). KDR (brown) positive cells are found in proximity with VEGF-positive cells (arrow). (c) Sham
joint shows a few VEGF-positive cells in deep zone of articular cartilage (arrowheads). Vascular endothelial cells are positive for KDR in bone
marrow, but not in proximity with VEGF-positive cells (arrows). (d) Negative control shows no specific staining. C: articular cartilage. B: bone. V:
vascular invasion. Bar = 200 μm in (a, c and d); and 100 μm in (b).
Pickarski et al. BMC Musculoskeletal Disorders 2011, 12:197
http://www.biomedcentral.com/1471-2474/12/197
Page 9 of 142-fold at week 4 to 6) of disease progression in ACLT
+MMx and ACLT models, respectively (Figure 6-a, b,
Table-2). Similar regulation patterns were also seen with
bone sialoprotein and osteopontin in these surgically-
induced models of OA (Table 2).
Discussion
Accumulating evidence supports the hypothesis that
subchondral bone remodeling in OA is a major
contributing factor to this degenerative disease [21]. The
integrity of articular cartilage depends on the mechani-
cal as well as biochemical properties of the underlying
bone [21,22]. In spontaneous OA animal models and in
OA patients, density and metabolism of the subchondral
bone have been suggested to occur prior to detectable
signs of cartilage damage [22-26]. We have previously
shown in the ACLT and ACLT+MMx models of OA in
rats, histological evidence demonstrating that joint
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occurring concomitantly and in proximity to surface
cartilage damage in early stage OA [16]. As the disease
advances, in OA animal models significant cartilage
thinning, subchondral bone sclerosis and osteophyte for-
mation has been observed [15,27-29].
To understand the molecular mechanisms of cartilage
degeneration and subchondral bone sclerosis and the
potentially coordinated signals between the two tissues
during OA progression, we developed a fast and uni-
form approach to collect together the articular cartilage
and subchondral bone tissues from the tibia of the
ACLT and ACLT+MMx models of OA in rats. Prior to
performing extensive genome-wide profiling of gene
expression and pathway analyses in these models, we
described here the validation of this approach by
demonstrating the time-dependent and sequential
changes in these tissues using real-time PCR and confir-
mation with immunohistochemical methods for genes
previously demonstrated to be involved in the pathogen-
esis of OA.
Previous studies have evaluated gene expression in
vivo either by means of global profiling, or by studying
subsets of collagenases or cytokines in articular cartilage
in similar experimental models of OA [30-33]. These
studies demonstrated that the gene expression changes
during the disease progression in animal models of OA
mimic that in human. Experimental models of OA pro-
vided important insights on key signaling pathway(s)
that involved proteases, cytokines or growth factors in
mediating OA pathogenesis. However, these early stu-
dies were primarily restricted to examining molecular
changes in the cartilage layer, without integrating infor-
mation from the pre-articular subchondral bone in
response to the surgically-induced joint instability.
Furthermore, these studies employed collection of
articular cartilage from the small joints of the rodent
[34,35], by pooling pieces of cartilage tissues shaved
from the bone surface. This method often results in
high variability in the amount and quality of RNA col-
lected from the joints. We sought to reduce this varia-
bility and investigate bone in addition to cartilage by
systematically collecting the tibial plateau slice contain-
ing both articular cartilage and the underlying subchon-
dral bone. Variability was further reduced by combining
slices from each cut within a group, and performing
replicate time-course studies. Expression levels of each
RNA pool were compared to expression levels from
sham operated joints for each independent study
increasing the confidence of gene expression changes
demonstrated. It should be noted that this does limit
the ability to detect animal specific changes within a
group. Also, inherent variability in biological models is
reflected in the degree of fold change demonstrated,
thus error bars are large in some instances although the
direction of change was always consistent. The reduc-
tion in the time of tissue collection by using serially col-
lected bone slices yields an additional advantage. Thus,
this method has potential application for high-through-
put collection of tibial plateaux tissues involved in OA
pathogenesis.
While our method has the advantage of consistently
sampling RNA for a global assessment of the joint tis-
sues, we recognize the approaches limitation to evaluate
the specific changes in bone or articular cartilage, due
to the common expression of many genes in both chon-
drocytes and osteoblasts. On the other hand, to support
the long-term genome-wide profiling efforts to increase
our understanding of the pathogenesis of the degenera-
tive joints in response to mechanical instability, we have
collected the combined subchondral bone and articular
cartilage from the spontaneous STR/ort mice [36] and
the surgically induced rat models. In addition, we have
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the subchondral bone from the ACLT-dogs and from
the humans with primary OA for array studies. By inte-
grating information for gene pathway analyses on these
tissues from multiple species, we believe this will pro-
vide a comprehensive approach to identify novel
mechanism(s) involved at multiple tissue levels during
OA progression.
Early degenerative changes have been reported in the
superficial zone of articular cartilage in both models and
consisted of proteoglycan loss and detectable surface
collagen damage, accompanied by increased chondrocyte
proliferation and hypertrophy within 2 weeks of surgery
[16,31,37,38]. Preceding the histological changes in the
A C L Ta n dA C L T + M M xj o i n t s ,w es h o w e dt h a tt h e
expression patterns of MMP-13 and aggrecanase-1,
responsible for degradation of collagen type II and of
proteoglycan core proteins, respectively, were quickly
and significantly up-regulated as early as the first week
post-surgery. Interestingly, expression of these proteases
remained significantly elevated above basal levels during
the 10 week study, confirming the important roles of
these enzymes in the continuous break down of tissues
within the joint as the disease progresses [39-41].
The onset of chondrogenic differentiation has been
confirmed by the appearance of glycosaminoglycan,
aggrecan and Col IIA, a splice variant of the Col II
gene, expression by chondroprogenitors in the extracel-
lular matrix [42]. The transcription factor Sox 9 is
required for mesenchymal condensation. Together with
Sox 5 and Sox 6, Sox 9 mediates chondrocyte differen-
tiation and expression of a series of chondrocyte-specific
marker genes including Col2a1, Col9a2, Col11a2 and
aggrecan [43]. Activation of Sox 9 is also important for
endochondral bone formation. In our hands, within the
first week post-surgery, gene markers for chondrocyte
differentiation, Col IIA and Sox 9, were highly upregu-
lated. However, unlike the markers of matrix degrada-
tion, expression levels of Col IIA declined by week 6
post-surgery, while Sox 9 was significantly reduced by
week 2 post-surgery. This finding may support the
hypothesis that early chondrocyte differentiation in
response to joint instability is an attempt to repair the
tissue during the early phase of disease progression [19].
Mesenchymal condensation and chondrocyte differentia-
tion have been implicated in the early stages of osteo-
phyte formation [44] and potentially, this upregulation
of Sox 9 and Col IIA may reflect the initial commitment
of the osteochondral progenitors to the development of
osteophytes in ACLT and ACLT+MMx models.
Normal adult articular cartilage remains avascular.
Vascularization of the articular cartilage, preceding sub-
chondral remodeling and osteophytosis, is a hallmark of
the pathology of OA [45]. Previously, in the ACLT and
ACLT+MMx model, vascular invasion into the calcified
deep layer of articular cartilage could be detected as
early as 2 weeks post-surgery [16]. Here, significantly
increased expression of the angiogenic factor VEGF was
detected at week 2 and remained elevated up to week 6
post-surgery in both models as compared to Sham.
Similar to VEGF, the expression profile of its receptor,
KDR, and the endothelial marker, CD31, were highly
upregulated at 2 weeks post-surgery. Interestingly, in the
osteochondral junction of the surgically-induced joints,
the CD31-positive blood vessels were frequently found
to be in proximity of the chondrocytes expressing
VEGF, suggesting early vascular invasion into cartilage
may lead to focal endochondral bone formation, and
subsequently to subchondral bone remodeling. This pro-
cess may eventually promote osteophytosis at the late
stage of disease progression. All immunohistochemical
observations are consistent with our previous histologi-
cal survey on vascularization in these rat models of OA
[17].
As determined by histological evaluation, vascular
invasion into calcified cartilage at the osteochondral
junction was almost always found together with the pre-
sence of osteoclasts, and preceded subchondral bone
sclerosis. We have reported previously in the ACLT and
ACLT+MMx models of OA, that subchondral osteope-
nia was significant ~2 weeks post-surgery, soon after the
initially observed focal surface cartilage damage and in
absence of marked cartilage thinning [16]. Indeed, the
bisphosphonate alendronate was demonstrated to retard
t h ed i s e a s ep r o g r e s s i o ni nt h eA C L Tm o d e lo fO Ai n
rats [46]. Even though multinucleated osteoclasts repre-
sent a very small fraction of the total cellular contents
in cartilage and bone tissues, upregulation (1.5 to 2-fold)
of osteoclast-specific markers, CatK and TRAP, was
readily detected in ACLT and ACLT+MMx joints as
early as 2 weeks post-surgery. This observation coupled
to subsequent subchondral bone remodeling may
explain the progressive elevation of these two markers
in the articular cartilage and subchondral bone slice in
the OA joints.
Changes in subchondral bone are believed to occur in
the later stage of OA, particularly osteophytosis. While
runx2/cbfa-1 is also expressed in hypertrophic chondro-
cytes, this transcription factor is the master gene of
bone formation [47]. Osterix is a runx2 dependent
osteoblast transcription factor, required for bone forma-
tion. Expression of runx2 and osterix together is funda-
mental for mesenchymal commitment to osteogenesis.
In addition to runx2 and osterix, we also determined
the regulation of two preferential matrix markers for
osteoblasts, bone sialoprotein and osteopontin. We
demonstrated that regulation profiles of the transcrip-
tion factors runx2 and osterix, as well as osteogenic
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by 6 week post-surgery; thus supporting previous histo-
logical findings demonstrating a significant increase in
subchondral bone sclerosis and osteophyte formation
toward the later stages of disease progression in these
two surgical models of OA [16]. Different from other
markers associated with cartilage changes, the degree of
change of the bone remodeling genes appeared to be
more severe in the ACLT+MMx relative to that in the
ACLT model. This is in agreement with previous histo-
logical findings [16] where osteophyte development in
ACLT+MMx model was found to be more severe than
that in ACLT model at week 6 and 10 post-surgery.
Conclusion
In summary, articular degeneration and bone sclerosis
are the most consistently observed characteristics of
osteoarthritis (OA). The surgically-induced joint
instability models of OA in rats, which resemble post-
traumatic OA in humans, are useful tools to study OA
pathogenesis. To evaluate the potential coordinating
molecular mechanisms of cartilage degeneration and
subchondral bone remodeling during disease progres-
sion, we developed a consistent and reliable method to
harvest both articular cartilage and subchondral bone
from the tibial plateaux of the surgically-induced joint
instability models of OA in rats. Here, we described the
validation of this approach by demonstrating the time-
dependent and sequential changes in gene expression
profiles of key markers for cartilage degradation, chon-
drocyte differentiation, vascular invasion and bone
remodeling in these tissues using real-time PCR and
confirmation with immunohistochemical methods. From
the experimental models and humans with OA, rich
sources of published information on the key pathways
regulated in the articular cartilage and synovium are
available [48,49]. However, the same type of information
for the subchondral bone is still lacking. To gain further
understanding of the sequential and cohesive regulation
of complex and potential novel biological pathways in
the joints during disease progression, the findings in this
study have focused our future efforts on genome-wide
profiling of gene expression and pathway analyses of the
subchondral cartilage and bone. Integrated information
on gene profiling of the subchondral bone during OA
progression will be analyzed by cross referencing the
results from the combined tissues to existing published
articular cartilage databases.
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